Cencora, Inc. · COR · Next earnings

Cencora, Inc. reports Wednesday, Feb 3, 2027

COR reports before market open with consensus EPS at $4.58 and revenue at $90.00B. Last quarter: Cencora leans on specialty growth as FY2027 expansion requires investment

Reports Before market open90 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $4.58 Calendar consensus
Consensus revenue $90.00B Calendar consensus
Report date Feb 3, 2027 Wednesday, date estimated
Session Before market open 90 days away

Where COR left off: FY2026 Q4

Full report

Cencora leans on specialty growth as FY2027 expansion requires investment

EPS surprise — Reported — vs $4.58
Revenue surprise — Reported — vs $87.95B
Stock move +4.0% Event window
Subsequent drift 0.0% Up to 20 sessions

Management’s FY2027 targets are 3–5% revenue growth, 4–6% operating income growth and 8–10% EPS growth. The prior quarter’s raised FY2026 adjusted EPS guidance was $17.75–$17.95; this call’s analysis describes FY2026 adjusted EPS of $17.97. No beat-or-miss conclusion is drawn here.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Integration and execution across recent acquisitions and the planned divestiture.
  • Potential reimbursement and policy changes affecting specialty margins.
  • Elevated capital spending and the scale and timing of the investment program.
  • Manufacturer price reductions, foreign-exchange headwinds and competition in specialty logistics and infusion services.

Questions analysts left open

  • How much specialty-segment growth is organic versus acquisition-driven.
  • Whether the new operating model and resegmentation improve execution as intended.
  • How reimbursement-policy changes could affect specialty margins.
  • Whether the scale and timing of the $1 billion investment program support expected returns.

Ask FN2 about COR next report

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the COR recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent COR quarters

All COR earnings

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q4

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.